Nets A/S: Stabilisation measures taken Company

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nets A/S: Stabilisation measures taken
Company announcement No. 17/2016     Nets A/S Lautrupbjerg 10 DK-2750 Ballerup   www.nets.eu Company Registration no. 37427497   4 October 2016

NOT FOR RELEASE OR DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

This announcement does not constitute an offering circular and nothing herein contains an offering of securities.

Stabilisation measures taken

With reference to company announcement no. 7/2016 dated 23 September 2016 regarding the beginning of the stabilisation period following the initial public offering and admission to trading and official listing of the temporary purchase certificates and the shares of Nets A/S ("Nets") on Nasdaq Copenhagen (the "Offering" or the "IPO"), Nets has received notification that Deutsche Bank AG, London Branch, acting as stabilising manager in the Offering, has taken the stabilisation measures set out in the attached notification with respect to the temporary purchase certificates and/or the shares of Nets.

- Ends -

For additional information, please contact

  Nets A/S Karsten Anker Petersen, Head of Group Communications Lars Oestmoe, Head of Investor Relations       +45 29 48 78 83 +47 913 47 177

Important notice

This announcement is not an offer to sell or a solicitation of any offer to buy any securities issued by Nets A/S (the "Company") in any jurisdiction where such offer or sale would be unlawful and the announcement and the information contained herein are not for distribution or release, directly or indirectly, in or into such jurisdictions.

This announcement and the information contained herein are not for distribution in or into the United States of America. This document does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase, any securities in the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) in reliance on Rule 144A.

In any member state of the European Economic Area ("EEA Member State"), other than Denmark, that has implemented Directive 2003/71/EC as amended (together with any applicable implementing measures in any member State, the "Prospectus Directive"), this communication is only addressed to and is only directed at investors in that EEA Member State who fulfil the criteria for exemption from the obligation to publish an offering memorandum, including qualified investors, within the meaning of the Prospectus Directive as implemented in each such EEA Member State.

This announcement is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the U.K. Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or (iii) high net worth entities falling within Article 49(2)(a) - (d) of the Order (the persons described in (i) through (iii) above together being referred to as "relevant persons"). The securities are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

In connection with the offering, Deutsche Bank AG, London Branch (the "Stabilising Manager") (or persons acting on behalf of the Stabilising Manager) may over-allot securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager (or persons acting on behalf of the Stabilising Manager) will undertake stabilisation. Any stabilisation action may begin on or after the date of commencement of trading and official listing of the securities on Nasdaq Copenhagen A/S and, if begun, may be ended at any time, but it must end no later than 30 days after the date of commencement of trading and official listing of the securities.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amgen's Board Gains Restaurateur Gibbs Amid Strategic Shift

Updated Category News Views 86

A Heavyweight Joiner Shakes Up Amgen's Ranks You can almost feel the ground shake when Amgen, a tech giant in biotech, ropes in a high-profile namesake from outside its usual league. David W. Gibbs, the former CEO of Yum! Brands, is now staking his claim at Amgen as a member of its Board of Directors. Effective immediately, Gibbs isn’t just a filler; he's diving...

Continue Reading
AI's Rise: Worth Watching for M&A Strategy Insights

Updated Category News Views 0

AI: The Hot Topic You Can't Ignore AI's rocking the boat like SEO did back in the day, folks. The Digital WOW is giving M&A Source® members a real scoop with their exclusive webinar, zeroing in on AI's potential seismic shifts in mergers and acquisitions. This should make any investor sit up and pay attention. AI's not just a tech buzzword anymore. It's like a strong cup...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 72

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Texas Instruments' $2B Notes Fuel Acquisition Ambitions

Updated Category News Views 128

Pushing Forward with Big Dollars Texas Instruments is setting the stage with an ambitious move by pricing $2.0 billion in investment-grade notes, preparing to shake things up with an acquisition. It's not every day you see a player like TXN dipping into the bond market with such confidence, yet here we are. Four series of senior unsecured notes are slated for issuance on...

Continue Reading
E-Filing: Why Ditching IRS Paper Forms Matters Now

Updated Category News Views 153

Tax Filing Today: The Old vs. The New Listen up, tax-filing warriors. Tackling that IRS Form 941 deadline isn’t just another play in the small business game—it’s crunch time. November 2, 2026, isn’t waiting around for excuses. Luckily, Halfpricesoft.com just chucked you a lifeline with their updated ezPaycheck platform. Swap that mountain of mangled paper forms...

Continue Reading
Custom Concrete: Crafting the Perfect Poolside Paradise

Updated Category News Views 48

Concrete: The Unsung Hero of Your Pool's Success You know, everyone always raves about that sparkling pool, but let's be real—it's the concrete holding the whole gig together. James White from White's Pools in Loganville, GA, drops some knowledge in a recent HelloNation piece about the unsung hero of backyard oases: custom concrete. Yeah, it's not sexy, but when you're...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 116

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading
Energy Fuels Secures Key Financing for Donald Project

Updated Category News Views 53

Donald Project: A Step Closer to Reality Look, when those rare earths start moving, the entire market gets a whiff of promise. Energy Fuels' Donald Rare Earth and Mineral Sands Project in Australia is gearing up for real action with a fresh funding nod. Export Finance Australia and the National Reconstruction Fund Corporation have conditionally greenlit up to A$180...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 93

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Brennan Takes a Swing: Barrasso Endorsement in Hand

Updated Category News Views 60

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...

Continue Reading

Top 5 Most Recently Viewed Articles

Rehabilitation Robots Market Growth and Future Opportunities

Updated Category News Views 187

The Future of Rehabilitation Robots As the healthcare landscape evolves, the rehabilitation robots market is witnessing remarkable growth, projected to reach approximately USD 1,776.24 million in the forthcoming years. This burgeoning sector aims to enhance the recovery processes for individuals across various age groups, especially the elderly, who often require...

Continue Reading
Kean University Strengthens Leadership with New Contract for Repollet

Updated Category News Views 152

Kean University’s New Chapter: A Strong Commitment to Leadership The Kean University Board of Trustees recently reached a pivotal decision about the university's future by approving a new five-year contract for President Lamont O. Repollet, Ed.D. This decision highlights the institution's dedication to transformative leadership as it works to enhance its reputation as a...

Continue Reading
Kura Sushi USA Prices Public Offering to Boost Growth Efforts

Updated Category News Views 327

Kura Sushi USA Public Offering Announcement Kura Sushi USA, Inc. (NASDAQ: KRUS), a pioneer in the technology-enabled Japanese dining experience, has recently priced a public offering of its Class A common stock. This strategic move is not just about fundraising; it reflects the Company's ambition to bolster its operational capacity and expand its reach. The offering...

Continue Reading
Grady Health System Receives Gold Plus Award for Excellence

Updated Category News Views 192

Grady Health System's Recognized Commitment to Stroke Care Grady Health System, home to the renowned Marcus Stroke and Neuroscience Center, has achieved the prestigious Gold Plus quality achievement award from the American Heart Association's Get With The Guidelines - Stroke program. This accolade highlights Grady's unwavering dedication to delivering exceptional stroke...

Continue Reading
Investors Urged to Act as Visa Faces Legal Challenges

Updated Category News Views 108

Investors Encouraged to Step Forward Amid Legal Investigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson is reaching out to investors who have suffered losses exceeding $100,000 in Visa to discuss their legal options directly. If you have experienced losses greater than $100,000 in Visa, it's essential to take action. You can connect with...

Continue Reading